Rubicon Research Limited
FDA inspection history in Satara, India, 2023
- 1
- Form 483
Every document, by year
- Form 483
2023: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2023One Form 483, at Satara, India.
Cited most
Across all Rubicon Research Limited observations on file
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.160General requirements1
- 21 CFR 211.48Plumbing1
The complete Rubicon Research Limited file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Satara, India
One Form 483 · 2023 · 3 observations
Latest: Form 483, Jan 27, 2023 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2023-01-27 | 483 Form 483 | Satara, India | 3 | $99 |
Investigators on these documents
FEI number 3012953979 · most recent document Jan 27, 2023
About Rubicon Research Limited
How many FDA Form 483s has Rubicon Research Limited received?
FDA Intel has 1 Form 483 on file for Rubicon Research Limited; the most recent is dated Jan 27, 2023.
When was Rubicon Research Limited last inspected by FDA?
The most recent FDA inspection document on file for Rubicon Research Limited is a Form 483 dated Jan 27, 2023, for the site in Satara, India.
What did FDA cite at Rubicon Research Limited?
The regulations cited most in the observations on file for Rubicon Research Limited are 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.160 (General requirements), 1 time.